Skip to main content
SpringerLink
Log in

ASCO guidelines for AEs due to immune checkpoint inhibitors

  • Guideline
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Brahmer JR et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology : 14 Feb 2018. Available from: URL: http://dx.doi.org/10.1200/JCO.2017.77.6385

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ASCO guidelines for AEs due to immune checkpoint inhibitors. Reactions Weekly 1691, 4 (2018). https://doi.org/10.1007/s40278-018-42259-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-42259-1

Search

Navigation